Subjects with fever
Conditions
Interventions
None listed
Sponsors
Medical Hospital, Tokyo Medical and Dental University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Subjects with two or more symptoms of clinical criteria for Kawasaki disease. Fever is essential symptom for inclusion to this study. 2. If Subjects have CALs, Subjects with one or more symptoms of Kawasaki disease clinical criteria including fever. 3. Subjects who have provided written informed consent by their guardians for participation in this study.
Exclusion criteria
Exclusion criteria: 1. Subjects who could not be diagnosed for Kawasaki disease or not by their medical record and clinical course. 2.Applicable for the following criteria 1) Collagen disease such as juvenile idiopathic arthritis 2) Autoinflammatory syndrome, such as Cryopirin-associated periodic syndrome 3) On systemic administration of immunosuppressant or steroid, except for inhaled steroid therapy and anti-allergic medicine 3. Subjects who are judged as unsuitable for this study by physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| o assess whether the addition of these proteins values concurrently with clinical diagnostic criteria is more effective than clinical diagnostic criteria alone, in the Kawasaki disease diagnosis setting | — |
Countries
Japan
Contacts
Public ContactMasakatsu Yanagimachi
Tokyo Medical and Dental University Department of Pediatrics
Outcome results
None listed